Source map — Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Endpoints News | news | 60% |
| STAT | news | 60% |
| BioSpace | news | 60% |
| TradingView | news | 60% |
| genomeweb.com | news | 60% |
| Fierce Biotech | news | 60% |
| www.prnewswire.com | news | 50% |
| www.rttnews.com | news | 50% |
| biotechreporter.news | news | 50% |
| www.quiverquant.com | news | 50% |
| www.finanznachrichten.de | news | 50% |
| www.nature.com | news | 50% |
| markets.financialcontent.com | news | 50% |
| www.marketscreener.com | news | 50% |
| www.biospace.com | news | 50% |
| finance.yahoo.com | news | 50% |
| biotech-insider.com | news | 50% |
| www.rarediseaseadvisor.com | news | 50% |
| www.thepharmaletter.com | news | 50% |
| business-news-today.com | news | 50% |
| catalystalert.io | news | 50% |
| briefglance.com | news | 50% |
| www.clinicaltrialsarena.com | news | 50% |
| biobriefs.com | news | 50% |